Hispanic paradox
Hispanic Paradox is a phenomenon in epidemiology where Hispanic and Latino populations in the United States tend to have health outcomes that are paradoxically better than those of their U.S.-born white counterparts, despite what their socioeconomic indicators would predict.
Overview[edit]
The term "Hispanic Paradox" was first coined by Kyriakos Markides and Karl Eschbach in 2005. It refers to the epidemiological finding that Hispanic and Latino populations have health outcomes that are comparable to, or in some cases better than, those of their U.S.-born white counterparts, despite being generally poorer and having less access to healthcare.
Possible Explanations[edit]
Several theories have been proposed to explain the Hispanic Paradox. These include:
- Healthy Migrant Effect: This theory suggests that immigrants are typically healthier than the average population in their home country, which could contribute to better health outcomes in the U.S.
- Salmon Bias: This theory proposes that unhealthy immigrants return to their home country to die, which could skew mortality statistics.
- Cultural Factors: This theory points to potential protective factors inherent in Hispanic culture, such as strong social support networks and dietary habits.
Criticisms[edit]
While the Hispanic Paradox has been widely reported, it has also been criticized. Some researchers argue that the paradox is an artifact of poor data collection and underreporting of Hispanic deaths. Others suggest that the paradox may disappear as Hispanics become more acculturated to U.S. society.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
